Giant Cell Glioblastoma — Trials

Giant Cell Glioblastoma — Trials · CancerIndex

Clinical trials

Registered studies

100 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: National Cancer Institute (NCI)
Termination share: 44.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (30)

clinicaltrialsPublishedShowing 1–9 of 9 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01478321	Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas	terminated	Phase 2	54	Northwestern UniversityOTHER	1	Mar 12, 2020	clinicaltrials
NCT01575275	Aminolevulinic Acid in Visualizing a Tumor During Surgery in Patients With Glioblastoma Multiforme	terminated	Phase 2	8	Michael Vogelbaum, MD, PhDOTHER	1	Jul 31, 2018	clinicaltrials